SMARTHEART Validation Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

128 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the accuracy of novel smartphone or wearable ECG devices to a gold standard ECG in patients with normal and abnormal ECGs.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The SMART-LV Pilot Study

NCT05630170

Left Ventricular Systolic Dysfunction

COMPLETED NA

Ambulatory Leadless Electrocardiogram Recorder Trial Feasibility

NCT05821465

Arrhythmias, Cardiac Palpitation Syncope +1 more

COMPLETED

AI-ECG Accessory Pathway Localisation Study

NCT07083791

Accessory Pathway Artifical Intelligence ECG

NOT_YET_RECRUITING

Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias

NCT05298553

Cardiac Arrhythmia Atrial Fibrillation

COMPLETED NA

Evaluation of Left Ventricular Autothreshold, Phase Two

NCT01242722

Heart Failure

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Assess the effect of the following on the accuracy of the recorded ECG compared to a gold standard ECG:

* Posture or position of the patient
* Movement
* Amount of hair on the ECG site
* Skin condition (tone/dryness) Ability to detect a paced rhythm accurately A qualitative assessment of ECG devices, including the amount of artefact in the signal and ease of use of the device

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant is willing and able to give informed consent for participation in the study.
* Must have an adequate understanding of written and spoken English
* Able (in the Investigators opinion) and willing to comply with study requirements.
* Must be over 18 years of age
* Must be deemed clinically stable by their direct care team.

Exclusion Criteria

* Subjects who do not have an adequate understanding of written and spoken English
* Patients who are medically unstable, as defined by the patient's direct care team.
* Patients who are unable to give informed consent
* Patients who are deemed clinically unstable by their direct care team

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No